Primary Record
urapidil
- In stock
- 5,777 g
- Purity
- 98.8 %
- CAS
- 34661-75-1
Compound Identifiers & Properties
- CAS
- 34661-75-1
- PubChem CID
- 5639
- SMILES
- CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
- Canonical SMILES
- COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1
Names & Synonyms
- urapidil
- Ebrantil
- Eupressyl
- Mediatensyl
- Uraprene
- 34661-75-1
- Urapidilum
- Urapidil hydrochloride
- urapidil(jan)
- uropidil
- Urapidil HCl
- Urapinil
- Ebrantil (TN)
- Urapidilum [INN-Latin]
- Urapidil (Standard)
- AAV-huTNFR:Fc
- TgAAV-TNFR:Fc
- A78GF17HJS
- Spectrum_001360
- Tocris-1772
- RAAV2-TNFR:Fc
- URAPIDIL 1G
- URAPIDIL 5G
- SpecPlus_000683
- UNII-A78GF17HJS
- Lopac-U-100
- URAPIDIL [INN]
- URAPIDIL [JAN]
- URAPIDIL [MI]
- urapidil monohydrochloride
- AC1L1KST
- AC1Q6CKO
- Urapidil [BAN:INN:JAN]
- Urapidil [INN:BAN:JAN]
- Prestwick0_000905
- Prestwick1_000905
- Prestwick2_000905
- Prestwick3_000905
- RefChem:933840
- Spectrum2_001172
- Spectrum3_001557
- Spectrum4_000233
- Spectrum5_001611
- TgAAC-94
- Urapidil (JP17/INN)
- C20H29N5O3
- URAPIDIL [MART.]
- DTXSID9021425
- D0K0VO
- D0M8BE
- URAPIDIL [WHO-DD]
- MLS003115907
- DTXCID501425
- Lopac0_001265
- MFCD00133908
- SCHEMBL48992
- BSPBio_000750
- BSPBio_003034
- KBioGR_000925
- KBioSS_001840
- C20H30ClN5O3
- DivK1c_006779
- NSC 310405
- NSC-310405
- RAAV-TNF, Targeted Genetics
- SPECTRUM1503100
- urapidil, 5-(14)C-labeled
- EINECS 252-130-4
- SPBio_001183
- SPBio_002949
- ICMGLRUYEQNHPF-UHFFFAOYSA-N
- BPBio1_000826
- CHEMBL279229
- orb1310879
- B-66256
- SCHEMBL29363219
- CHEBI:32278
- CTK4H2778
- ERK5-6D04
- GTPL13357
- HY-B0716R
- KBio1_001723
- KBio2_001840
- KBio2_004408
- KBio2_006976
- KBio3_002534
- BRN 0725782
- C02CA06
- CID5639
- 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
- BCPP000025
- GLXC-23793
- HMS1922E11
- HMS5087C11
- urapidil, 2,3-(14)C2-labeled
- BCP02494
- CID:5639
- HY-B0716
- KS-000016PV
- MSK10703
- ZINC1544805
- Tox21_110298
- AR-1L7976
- BDBM50237617
- CCG-40329
- NCGC00016066-07
- NSC310405
- s5965
- STL454353
- AKOS015896920
- C20-H29-N5-O3
- AC-8246
- AN-6319
- CS-O-02543
- DB12661
- EBC-219033
- FU34927
- KS-5208
- SDCCGSBI-0051232.P004
- VZ34075
- NCGC00016066-01
- NCGC00016066-02
- NCGC00016066-03
- NCGC00016066-04
- NCGC00016066-05
- NCGC00016066-06
- NCGC00016066-08
- NCGC00016066-09
- NCGC00016066-10
- NCGC00016066-11
- NCGC00016066-16
- NCGC00016066-22
- NCGC00025290-01
- NCGC00025290-02
- NCGC00025290-03
- NCGC00025290-04
- NCGC00025290-05
- NCGC00178336-01
- NCGC00178336-02
- 4CA-1304
- H964
- J19.690H
- SMR001831470
- SY053321
- BCP0726000257
- SBI-0051232.P003
- SID:134223190
- AB1009497
- CAS-34661-75-1
- CAS-64887-14-5
- LS-158663
- 1710B
- 6-(3-(4-(o-Methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil
- 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
- AB00514699
- CS-0009600
- FT-0639207
- NS00009232
- U0085
- 5-25-15-00402 (Beilstein Handbook Reference)
- A17074
- B66256
- D01333
- F15008
- K-7882
- AB00053328_10
- AB00053328_11
- 661U751
- A822334
- B 66256
- C015568
- L005359
- Q418922
- Urapidil =98.0% (by HPLC, titration analysis)
- I07-0038
- 6-((3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
- 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
- BRD-K73196317-001-02-7
- BRD-K73196317-003-03-1
- BRD-K73196317-003-07-2
- BRD-K73196317-003-13-0
- BRD-K73196317-003-14-8
- BRD-K73196317-003-15-5
- Gene therapy (rheumatoid arthritis), Targeted Genetics
- 6-((3-(4-(o-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyluracil
- 2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-
- 6-((3-(4-(2-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
- 6-[[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
- 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione
- URACIL, 1,3-DIMETHYL-6-(3-(4-(o-METHOXYPHENYL)-1-PIPERAZINYL)PROPPYLAMINO)-
- 1,3-dimethyl-6-[(3-{4-[2-(methyloxy)phenyl]piperazin-1-yl}propyl)amino]pyrimidine-2,4(1H,3H)-dione
- 1,3-Dimethyl-6-[3-[4-(o-methoxyphenyl)piperazin-1-yl]propylamino]uracil
- 2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
- 6-((3-(4- (2-methoxyphenyl)-1-piperazinyl)propyl)amino)- 1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
- 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
- 6-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethyluracil
- 6-[3-[4-(2-Methoxyphenyl)piperazinyl]propylamino]-1,3-dimethyluracil
- 6-[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethyluracil
- Uracil,3-dimethyl-6-[3-[4-(o-methoxyphenyl)-1-piperazinyl]proppylamino]-
- Uracil, 1,3-dimethyl-6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-
- 102411-11-0
- 115787-68-3
- 2,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
- 2,4(1H,3H)-Pyrimidinedione,6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
- 252-130-4
- 6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 6-((3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione #
- 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 64887-14-5
- 6639-43-6
- BKU
- Ebrantil, 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]- amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione